Amgen 386 for Recurrent Glioblastoma

Share this content:
Amgen 386 for Recurrent Glioblastoma
 
Sponsors and Collaborators
Duke University
Amgen
 
Contact
Susan Boulton
919-668-0896
 
Karen Carter
919-668-2329
 
Principal Investigators
David Reardon, MD
Duke University Health System
 
ClinicalTrials.gov Identifier
NCT01290263

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs